181 related articles for article (PubMed ID: 18676852)
1. Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells.
Chang CC; Shieh GS; Wu P; Lin CC; Shiau AL; Wu CL
Cancer Res; 2008 Aug; 68(15):6281-91. PubMed ID: 18676852
[TBL] [Abstract][Full Text] [Related]
2. Tumor-selective replication of an oncolytic adenovirus carrying oct-3/4 response elements in murine metastatic bladder cancer models.
Wu CL; Shieh GS; Chang CC; Yo YT; Su CH; Chang MY; Huang YH; Wu P; Shiau AL
Clin Cancer Res; 2008 Feb; 14(4):1228-38. PubMed ID: 18281558
[TBL] [Abstract][Full Text] [Related]
3. Introduction of insulin-like growth factor binding protein-2 gene into human bladder cancer cells enhances their metastatic potential.
Miyake H; Hara I; Yamanaka K; Muramaki M; Gleave M; Eto H
Oncol Rep; 2005 Feb; 13(2):341-5. PubMed ID: 15643522
[TBL] [Abstract][Full Text] [Related]
4. Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.
Darini CY; Pisani DF; Hofman P; Pedeutour F; Sudaka I; Chomienne C; Dani C; Ladoux A
Oncogene; 2012 May; 31(19):2438-49. PubMed ID: 21927026
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases and bladder cancer.
Kanayama H
J Med Invest; 2001 Feb; 48(1-2):31-43. PubMed ID: 11286015
[TBL] [Abstract][Full Text] [Related]
6. [Prospects for molecular research in urological oncology: bladder cancer].
Koshida K; Imao T; Ito H; Miyagi T; Konaka H; Mizokami A; Egawa M; Namiki M
Hinyokika Kiyo; 2001 Nov; 47(11):815-8. PubMed ID: 11771177
[TBL] [Abstract][Full Text] [Related]
7. Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines.
Miyake H; Yoshimura K; Hara I; Eto H; Arakawa S; Kamidono S
J Urol; 1997 Jun; 157(6):2351-5. PubMed ID: 9146669
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin.
Miyata Y; Sagara Y; Kanda S; Hayashi T; Kanetake H
Hum Pathol; 2009 Apr; 40(4):496-504. PubMed ID: 19121849
[TBL] [Abstract][Full Text] [Related]
9. Dominant role of E-cadherin in the progression of bladder cancer.
Imao T; Koshida K; Endo Y; Uchibayashi T; Sasaki T; Namiki M
J Urol; 1999 Feb; 161(2):692-8. PubMed ID: 9915485
[TBL] [Abstract][Full Text] [Related]
10. Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer.
Kawanishi H; Matsui Y; Ito M; Watanabe J; Takahashi T; Nishizawa K; Nishiyama H; Kamoto T; Mikami Y; Tanaka Y; Jung G; Akiyama H; Nobumasa H; Guilford P; Reeve A; Okuno Y; Tsujimoto G; Nakamura E; Ogawa O
Clin Cancer Res; 2008 May; 14(9):2579-87. PubMed ID: 18451219
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-9 (MMP-9) immunoreactive protein in urinary bladder cancer: a marker of favorable prognosis.
Vasala K; Pääkko P; Turpeenniemi-Hujanen T
Anticancer Res; 2008; 28(3B):1757-61. PubMed ID: 18630455
[TBL] [Abstract][Full Text] [Related]
12. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
[TBL] [Abstract][Full Text] [Related]
13. The role of actinin-4 in bladder cancer invasion.
Koizumi T; Nakatsuji H; Fukawa T; Avirmed S; Fukumori T; Takahashi M; Kanayama H
Urology; 2010 Feb; 75(2):357-64. PubMed ID: 19969329
[TBL] [Abstract][Full Text] [Related]
14. Oct-3/4 promotes migration and invasion of glioblastoma cells.
Kobayashi K; Takahashi H; Inoue A; Harada H; Toshimori S; Kobayashi Y; Goto K; Sugimoto K; Yano H; Ohnishi T; Tanaka J
J Cell Biochem; 2012 Feb; 113(2):508-17. PubMed ID: 21938739
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of the role and relationship between Notch-1 and Oct-4 expression in urinary bladder carcinoma.
Abdou AG; El-Wahed MM; Kandil MA; Samaka RM; Elkady N
APMIS; 2013 Oct; 121(10):982-96. PubMed ID: 23594289
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside G(M3) overexpression induces apoptosis and reduces malignant potential in murine bladder cancer.
Watanabe R; Ohyama C; Aoki H; Takahashi T; Satoh M; Saito S; Hoshi S; Ishii A; Saito M; Arai Y
Cancer Res; 2002 Jul; 62(13):3850-4. PubMed ID: 12097299
[TBL] [Abstract][Full Text] [Related]
17. Identification of DPPA4 and other genes as putative Sox2:Oct-3/4 target genes using a combination of in silico analysis and transcription-based assays.
Chakravarthy H; Boer B; Desler M; Mallanna SK; McKeithan TW; Rizzino A
J Cell Physiol; 2008 Sep; 216(3):651-62. PubMed ID: 18366076
[TBL] [Abstract][Full Text] [Related]
18. Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy.
Beecken WD; Engl T; Jonas D; Blaheta RA
Int J Mol Med; 2009 Feb; 23(2):261-6. PubMed ID: 19148551
[TBL] [Abstract][Full Text] [Related]
19. Bladder cancer angiogenesis and metastasis--translation from murine model to clinical trial.
Black PC; Dinney CP
Cancer Metastasis Rev; 2007 Dec; 26(3-4):623-34. PubMed ID: 17726580
[TBL] [Abstract][Full Text] [Related]
20. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
